MAPK3 and neoplasm: The authors argued that ERK1/2‐dependent DRP1 phosphorylation increased mitochondrial fission to support tumour cell growth but this in turn conferred a vulnerability such that cells with phosphomimetic Ser616Asp DRP1 mutant became addicted to ERK1/2 signalling and underwent apoptosis upon ERK1/2 inhibition.